13 YEARS
OF INNOVATIVE CLINICAL RESEARCH

FROM BARCELONA TO BOSTON, AND WITH A PRESENCE IN OVER 14 COUNTRIES, TODAY WE’RE CELEBRATING MORE THAN JUST AN ANNIVERSARY. WE’RE CELEBRATING 13 YEARS DEDICATED TO A MISSION THAT DRIVES US EVERY DAY: ADVANCING CANCER RESEARCH GLOBALLY THROUGH INNOVATION, SCIENTIFIC EXCELLENCE AND INTERNATIONAL COLLABORATION.

WE CONNECT THE BEST TREATMENTS WITH THE BRIGHTEST MINDS

MEDSIR is a company founded by scientific experts in 2012. We are dedicated to the design and management of strategic clinical trials in oncology, from study conception to the publication of study results.

MEDSIR favors a new model for collaborative clinical research in oncology development that aims to combine the highest scientific value with the strategic development of novel cancer treatments, with the final goal of benefiting cancer patients worldwide. Our goal is to generate win-win scenarios for all stakeholders involved in independent clinical research.

TOGETHER WE CAN BUILD A BRIGHTER FUTURE

MEDSIR ONCOCLÍNICAS ACADEMY

MEDSIR and Oncoclínicas & Co. teamed up to launch the MEDSIR Oncoclínicas Academy, an educational project aiming to elevate clinical research expertise globally. In the past edition, a group of Medical Oncologists specialized in breast cancer from Brazil, attended a 5-day program in Barcelona, Spain.

The hands-on experience in a hospital and the workshops led by experts and KOLs, resulted in an increase of the group’s expertise in the design and management of clinical trials, offering both a scientific and operational perspective while delineating their roles and responsibilities as Principal Investigators.

WHAT WE DO

Our international team of high-level clinicians and research experts are passionate about collaborating with medical oncologists and pharmaceutical companies to develop the best treatments for patients as quickly as possible.